Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase

Citation
Mp. Schneider et al., Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase, J HYPERTENS, 18(12), 2000, pp. 1767-1773
Citations number
31
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF HYPERTENSION
ISSN journal
02636352 → ACNP
Volume
18
Issue
12
Year of publication
2000
Pages
1767 - 1773
Database
ISI
SICI code
0263-6352(200012)18:12<1767:FGTOTG>2.0.ZU;2-Y
Abstract
Objectives To test whether the Glu298Asp polymorphism of the endothelial ni tric oxide synthase (eNOS) gene is of functional relevance in humans by alt ering endothelium-dependent vasodilation, Background The Asp298 variant of the eNOS gene product has been associated with arterial hypertension, coronary artery disease and myocardial infarcti on. The pathogenetic mechanism has not yet been elucidated, Since endotheli um-dependent vasodilation has been shown to be impaired in these disorders, we hypothesized that the Glu298Asp polymorphism of the eNOS gene influence s endothelium-dependent vasodilation, Methods In 80 patients with normal or elevated cholesterol, endothelium-dep endent and -independent vasodilation was assessed. Forearm blood flow was m easured by plethysmography in response to intra-arterial (i.a.) infusion of 12 and 48 mug/min acetylcholine and 3.2 and 12.8 mug/min nitroprusside, re spectively. N-G-monomethyl-L-arginine (L-NMMA) in doses of 4, 8 and 16 mu m ol/min was infused to test basal nitric oxide (NO) production and release. Genomic DNA was extracted from brood samples to determine the Glu298Asp pol ymorphism of the eNOS gene at position 1917 GTT after BanII restriction. Results Baseline parameters (age, gender, blood pressure, body mass index, cholesterol level) were similar across the genotypes, Genotype frequencies did not deviate from the Hardy-Weinberg equilibrium. No differences in fore arm brood flow to i.a, acetylcholine (average increase: + 554 +/- 371%), ni troprusside or L-NMMA infusion were found across the eNOS genotypes, neithe r for endothelium-dependent or endothelium-independent vasodilation, nor fo r basal NO production and release, Our sample size of n = 80 had a power of > 80% (beta = 0.20) with a P value < 0.05 (<alpha> = 0.05) to detect a 200 % difference in forearm brood flow response to 48 mug/min acetylcholine. Conclusions At a power of 80%, we can exclude a relevant effect on endothel ium-dependent vasodilation due to the eNOS Glu298Asp polymorphism. Thus, ou r functional genetic study does not suggest any biological effect of the eN OS Glu298Asp genotype on the cardiovascular system via an influence on endo thelium-dependent vasodilation. (C) 2000 Lippincott Williams & Wilkins.